| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 15b | 0.532 | 0.769 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 96 | 0.536 | 0.769 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 381 | 0.584 | 0.654 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
sodium voltage-gated channel alpha subunit 10 | 0.566 | 0.692 | 9.9E-38 |
|
phenotype | 0.620 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.570 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
calpain 2 | 0.590 | 0.692 | 3.5E-22 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
anoctamin 3 | 0.716 | 0.385 | 1.2E-17 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
integrin subunit alpha 1 | 0.644 | 0.654 | 2.6E-16 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2014 | 2014 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2012 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
phenotype | 0.560 | None | 0.958 | 1 | 0 | 1988 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.270 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
neurotensin receptor 1 | 0.563 | 0.692 | 1.9E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
regulator of G protein signaling 4 | 0.621 | 0.577 | 5.1E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 1997 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2017 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
integrin subunit alpha 3 | 0.573 | 0.731 | 3.6E-07 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
phenotype | 0.520 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
CGRP receptor component | 0.821 | 0.154 | 9.0E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 |